These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33482143)

  • 21. Characterization of Oropharyngeal Carriage Isolates of Neisseria meningitidis in Healthy Korean Adolescents in 2015.
    Kim HW; Lee S; Kwon D; Cha J; Ahn JG; Kim KH
    J Korean Med Sci; 2017 Jul; 32(7):1111-1117. PubMed ID: 28581267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.
    Kristiansen PA; Diomandé F; Wei SC; Ouédraogo R; Sangaré L; Sanou I; Kandolo D; Kaboré P; Clark TA; Ouédraogo AS; Absatou KB; Ouédraogo CD; Hassan-King M; Thomas JD; Hatcher C; Djingarey M; Messonnier N; Préziosi MP; LaForce M; Caugant DA
    Clin Vaccine Immunol; 2011 Mar; 18(3):435-43. PubMed ID: 21228139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine.
    Read RC; Dull P; Bai X; Nolan K; Findlow J; Bazaz R; Kleinschmidt A; McCarthy M; Wang H; Toneatto D; Borrow R
    Vaccine; 2017 Jan; 35(3):427-434. PubMed ID: 27912986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010.
    Sáfadi MA; Carvalhanas TR; Paula de Lemos A; Gorla MC; Salgado M; Fukasawa LO; Gonçalves MG; Higa F; Brandileone MC; Sacchi CT; Ribeiro AF; Sato HK; Bricks LF; Cassio de Moraes J
    Emerg Infect Dis; 2014 May; 20(5):806-11. PubMed ID: 24751156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningococcal carriage among Georgia and Maryland high school students.
    Harrison LH; Shutt KA; Arnold KE; Stern EJ; Pondo T; Kiehlbauch JA; Myers RA; Hollick RA; Schmink S; Vello M; Stephens DS; Messonnier NE; Mayer LW; Clark TA
    J Infect Dis; 2015 Jun; 211(11):1761-8. PubMed ID: 25505298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meningococcal carriage in relation to an outbreak of invasive disease due to Neisseria meningitidis serogroup C in the Netherlands.
    Conyn-van Spaendonck MA; Reintjes R; Spanjaard L; van Kregten E; Kraaijeveld AG; Jacobs PH
    J Infect; 1999 Jul; 39(1):42-8. PubMed ID: 10468128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, serogroup distribution and risk factors of Neisseria meningitidis carriage in high school and university students in Hungary.
    Huber A; Kovács E; Horváth A; Sahin-Tóth J; Kaptás Á; Juhász E; Kristóf K; Dobay O
    Vaccine; 2024 Apr; 42(9):2271-2277. PubMed ID: 38423809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].
    Daugla DM; Gami JP; Gamougam K; Naibei N; Mbainadji L; Narbé M; Toralta J; Kodbesse B; Ngadoua C; Coldiron ME; Fermon F; Page AL; Djingarey MH; Hugonnet S; Harrison OB; Rebbetts LS; Tekletsion Y; Watkins ER; Hill D; Caugant DA; Chandramohan D; Hassan-King M; Manigart O; Nascimento M; Woukeu A; Trotter C; Stuart JM; Maiden M; Greenwood BM
    Lancet; 2014 Jan; 383(9911):40-47. PubMed ID: 24035220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling study.
    Campbell H; Andrews N; Parikh SR; White J; Edelstein M; Bai X; Lucidarme J; Borrow R; Ramsay ME; Ladhani SN
    Lancet Child Adolesc Health; 2022 Feb; 6(2):96-105. PubMed ID: 34883094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.
    Bijlsma MW; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
    Clin Infect Dis; 2014 Nov; 59(9):1216-21. PubMed ID: 25069869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy.
    Jeppesen CA; Snape MD; Robinson H; Gossger N; John TM; Voysey M; Ladhani S; Okike IO; Oeser C; Kent A; Oliver J; Taylor P; Morales-Aza B; Clarke SC; Casey M; Martins F; Kitchin NR; Anderson AS; Jones H; Jansen KU; Eiden J; Pedneault L; Heath PT; Finn A; Faust SN; Pollard AJ
    J Infect; 2015 Jul; 71(1):43-52. PubMed ID: 25709085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso.
    Ba AK; Sanou I; Kristiansen PA; Sangaré L; Ouédraogo R; Ouattara K; Kienou M; Tiendrebeogo S; Tranchot J
    BMC Infect Dis; 2014 Oct; 14():546. PubMed ID: 25311771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine.
    Topaz N; Kristiansen PA; Schmink S; Congo-Ouédraogo M; Kambiré D; Mbaeyi S; Paye M; Sanou M; Sangaré L; Ouédraogo R; Wang X
    Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33332261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia.
    Marshall HS; Lally N; Flood L; Phillips P
    Med J Aust; 2020 Feb; 212(2):89-93. PubMed ID: 31909501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidis.
    McMillan M; Koehler AP; Lawrence A; Sullivan TR; Bednarz J; MacLennan JM; Maiden MCJ; Ladhani SN; Ramsay ME; Trotter C; Borrow R; Finn A; Kahler CM; Whelan J; Vadivelu K; Richmond PC; Marshall HS
    J Infect Dis; 2022 Feb; 225(4):637-649. PubMed ID: 34487174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.
    MenAfriCar consortium
    J Infect Dis; 2015 Oct; 212(8):1298-307. PubMed ID: 25858956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak-Oregon, 2015-2016.
    McNamara LA; Thomas JD; MacNeil J; Chang HY; Day M; Fisher E; Martin S; Poissant T; Schmink SE; Steward-Clark E; Jenkins LT; Wang X; Acosta A;
    J Infect Dis; 2017 Nov; 216(9):1130-1140. PubMed ID: 28968661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.
    Davis K; Valente Pinto M; Andrews NJ; Goldblatt D; Borrow R; Findlow H; Southern J; Partington J; Plested E; Patel S; Holland A; Matheson M; England A; Hallis B; Miller E; Snape MD
    Lancet Infect Dis; 2021 May; 21(5):688-696. PubMed ID: 33428870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.